SNDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

25.78

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

0.19

EPS Last/This Y

1.69

EPS This/Next Y

1.24

Price

20.41

Target Price

38.27

Analyst Recom

1.08

Performance Q

-0.68

Upside

-532.4%

Beta

0.37

Ticker: SNDX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	SNDX	24.14	0.11	0.11	17701
2026-07-15	SNDX	23.5	0.11	0.05	17725
2026-07-16	SNDX	22.79	0.11	0.06	17723
2026-07-17	SNDX	22.76	0.11	0.13	17775
2026-07-20	SNDX	22.28	0.12	1.30	12917
2026-07-21	SNDX	22.63	0.14	0.13	13202
2026-07-22	SNDX	22.05	0.14	0.22	13416
2026-07-23	SNDX	21.21	0.14	2.33	13455
2026-07-24	SNDX	20.8	0.15	0.09	13562
2026-07-27	SNDX	20.53	0.15	1.28	13578
2026-07-28	SNDX	19.64	0.17	0.95	14020
2026-07-29	SNDX	19.21	0.17	2.39	14090
2026-07-30	SNDX	19.48	0.18	999.99	14228
2026-07-31	SNDX	19.04	0.18	0.10	14243
2026-08-03	SNDX	19.24	0.18	0.56	14369
2026-08-04	SNDX	18	0.19	0.97	14404
2026-08-05	SNDX	19.93	0.22	0.33	15175
2026-08-06	SNDX	19.76	0.22	0.90	15379
2026-08-07	SNDX	20.39	0.24	0.14	15879
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	SNDX	24.15	43.8	-	-1.70
2026-07-15	SNDX	23.51	43.8	-	-1.70
2026-07-16	SNDX	22.69	43.8	-	-1.70
2026-07-17	SNDX	22.80	43.8	-	-1.70
2026-07-20	SNDX	22.28	43.8	-	-1.70
2026-07-21	SNDX	22.64	44.1	-	-1.68
2026-07-22	SNDX	22.07	44.1	-	-1.68
2026-07-23	SNDX	21.22	44.1	-	-1.68
2026-07-24	SNDX	20.81	44.1	-	-1.68
2026-07-27	SNDX	20.53	44.1	-	-1.68
2026-07-28	SNDX	19.64	47.4	-	-1.60
2026-07-29	SNDX	19.24	47.4	-	-1.60
2026-07-30	SNDX	19.48	47.4	-	-1.60
2026-07-31	SNDX	19.05	47.4	-	-1.60
2026-08-03	SNDX	19.22	47.4	-	-1.60
2026-08-04	SNDX	19.22	47.4	-	-1.60
2026-08-05	SNDX	19.94	47.4	-	-1.60
2026-08-06	SNDX	19.76	47.4	-	-1.60
2026-08-07	SNDX	20.41	47.4	-	-1.60
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	SNDX	-1.70	0.31	27.01
2026-07-15	SNDX	-1.70	0.31	27.01
2026-07-16	SNDX	-1.70	0.31	27.01
2026-07-17	SNDX	-1.70	0.31	27.01
2026-07-20	SNDX	-1.70	0.80	27.01
2026-07-21	SNDX	-1.70	0.80	27.01
2026-07-22	SNDX	-1.70	0.80	27.01
2026-07-23	SNDX	-1.70	0.80	27.01
2026-07-24	SNDX	-1.70	0.80	27.01
2026-07-27	SNDX	-1.70	0.80	25.78
2026-07-28	SNDX	-1.70	0.80	25.78
2026-07-29	SNDX	-1.70	0.80	25.78
2026-07-30	SNDX	-1.70	0.80	25.78
2026-07-31	SNDX	-1.70	0.80	25.78
2026-08-03	SNDX	-1.70	1.88	25.78
2026-08-04	SNDX	-1.70	1.88	25.78
2026-08-05	SNDX	-1.70	1.88	25.78
2026-08-06	SNDX	-1.70	1.88	25.78
2026-08-07	SNDX	-1.57	1.88	25.78
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.55

Avg. EPS Est. Current Quarter

-0.44

Avg. EPS Est. Next Quarter

-0.36

Insider Transactions

-1.57

Institutional Transactions

1.88

Beta

0.37

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.7

Max Drawdown 5-Year %

-69.9

Target Price

38.27

P/E

Forward P/E

PEG

P/S

7.22

P/B

120.45

P/Free Cash Flow

EPS

-2.52

Average EPS Est. Cur. Y

-1.6

EPS Next Y. (Est.)

-0.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-87.52

Relative Volume

0.64

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.1

EBIT Estimation

◆ SNDX Healthcare

$20.40

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

9/15

Valuation

10/20

TP/AR

2/10

Options

8/10

RSI

48.1

Range 1M

35.7%

Sup Dist

5.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

24/30

Estimates

0/20

Inst/Vol

4/15

Options

8/10

EPS Yr

42.6%

EPS NY

64.4%

52W%

59.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +87.6% upside

Quality

6/30

Valuation

14/30

Growth

18/25

Stability

6/10

LT Trend

0/5

Upside

+87.6%

Quality

SNDX — P/E HistoricalBiotechnology

Syndax Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 298

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

SNDX

Latest News

—

Caricamento notizie per SNDX…

stock quote shares SNDX – Syndax Pharmaceuticals, Inc. Stock Price stock today

news today SNDX – Syndax Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SNDX – Syndax Pharmaceuticals, Inc. yahoo finance google finance

stock history SNDX – Syndax Pharmaceuticals, Inc. invest stock market

stock prices SNDX premarket after hours

ticker SNDX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y